By Stephen Nakrosis
Aytu BioPharma said Ryan Selhorn has been named as the company's chief financial officer, treasurer and corporate secretary, effective Nov. 11.
He succeeds Mark Oki as CFO. Oki will continue to consult for the company through Dec. 1.
Prior to being named CFO, Selhorn served as EVP, finance and business optimization, since November 2022, the company said. Before that, he was SVP, finance and operations, consumer healthcare division, and also served as VP, finance, consumer healthcare division.
Selhorn also served as VP and CFO at Innovus Pharmaceuticals, and as CFO and chief accounting officer of Signature Analytics, Aytu said.
Selhorn will receive an annual base salary of $400,000.
Write to Stephen Nakrosis at stephen.nakrosis@wsj.com
(END) Dow Jones Newswires
November 13, 2024 18:53 ET (23:53 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。